HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tamotsu Kiyoshima Selected Research

Kimura Disease

1/2022Distinct disease-specific Tfh cell populations in 2 different fibrotic diseases: IgG4-related disease and Kimura disease.
12/2019Tissue-infiltrating immune cells contribute to understanding the pathogenesis of Kimura disease: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tamotsu Kiyoshima Research Topics

Disease

16Neoplasms (Cancer)
08/2022 - 11/2012
13Squamous Cell Carcinoma of Head and Neck
01/2020 - 07/2005
6Immunoglobulin G4-Related Disease
01/2022 - 10/2015
4Sialadenitis
03/2020 - 02/2015
3Dacryocystitis (Dacryoadenitis)
03/2020 - 02/2015
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2017 - 03/2006
2Adenoid Cystic Carcinoma (Cylindroma)
08/2022 - 01/2018
2Ameloblastoma
01/2022 - 01/2013
2Fibrosis (Cirrhosis)
01/2022 - 02/2016
2Kimura Disease
01/2022 - 12/2019
2Odontoma
12/2019 - 01/2013
2Neoplasm Metastasis (Metastasis)
11/2017 - 02/2016
1Dental Enamel Hypomineralization
01/2022
1Melanoma (Melanoma, Malignant)
11/2021
1Carcinogenesis
01/2020
1Granuloma
12/2019
1Eosinophilia
12/2019
1Periodontitis
12/2019
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
12/2019
1Renal Cell Carcinoma (Grawitz Tumor)
08/2019
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2018
1Rheumatoid Arthritis
02/2018
1Osteonecrosis (Kienbock's Disease)
02/2018
1Lymphatic Metastasis
02/2016
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
10/2015
1Disease Progression
10/2015
1Glomerulonephritis
10/2015
1Residual Neoplasm
05/2015
1Oral Lichen Planus
04/2015
1Mikulicz' Disease
02/2015
1Colorectal Neoplasms (Colorectal Cancer)
11/2010
1Psoriasis (Pustulosis Palmaris et Plantaris)
03/2006

Drug/Important Bio-Agent (IBA)

9Immunoglobulin G (IgG)IBA
01/2022 - 02/2015
5CytokinesIBA
01/2022 - 04/2015
2Semaphorin-3AIBA
08/2022 - 12/2019
2Proteins (Proteins, Gene)FDA Link
07/2022 - 02/2016
2Immunoglobulin E (IgE)IBA
01/2022 - 12/2019
2Interleukin-10 (Interleukin 10)IBA
01/2022 - 11/2017
2CateninsIBA
12/2019 - 01/2018
1Semaphorins (Semaphorin)IBA
08/2022
1ADP-Ribosylation Factors (ADP-Ribosylation Factor)IBA
07/2022
15-Methylcytosine (5 Methylcytosine)IBA
07/2022
1Protein Isoforms (Isoforms)IBA
07/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1Interleukin-13IBA
01/2022
1Calcium Carbonate (Limestone)FDA Link
01/2022
1Mitogen-Activated Protein KinasesIBA
01/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022
1Cadherins (E-Cadherin)IBA
11/2021
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
11/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
12/2020
1Interleukin-33IBA
01/2020
1CationsIBA
01/2020
1PlasticsIBA
01/2020
1Toll-Like Receptor 7IBA
01/2020
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2020
1LipopolysaccharidesIBA
12/2019
1AntigensIBA
12/2019
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2019
1Celecoxib (Celebrex)FDA Link
12/2019
1Epidermal Growth Factor (EGF)IBA
10/2019
1TeaIBA
08/2019
1MicroRNAs (MicroRNA)IBA
10/2018
1VimentinIBA
09/2018
1Bevacizumab (Avastin)FDA Link
06/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2018
1Diphosphonates (Bisphosphonates)IBA
02/2018
1Methotrexate (Mexate)FDA LinkGeneric
02/2018
1Interleukin-4 (Interleukin 4)IBA
01/2018
1Peptide Hydrolases (Proteases)FDA Link
12/2017
1Kallikreins (Kallikrein)IBA
12/2017
1Keratin-17 (Keratin 17)IBA
08/2017
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2017
1ORALIT (ORS)IBA
02/2016
1Transcription Factors (Transcription Factor)IBA
02/2016
1Pattern Recognition ReceptorsIBA
02/2016
1Brachyury protein (Brachyury)IBA
02/2016
1DNA (Deoxyribonucleic Acid)IBA
02/2016
1Transcription Factor 4IBA
02/2016
1SteroidsIBA
10/2015
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
05/2015
1Interleukin-6 (Interleukin 6)IBA
05/2015
1tuftelin (enamelin)IBA
01/2013
1Protons (Proton)IBA
01/2013
1ThymosinIBA
01/2013
1Adenosine Triphosphatases (ATPase)IBA
01/2013
1Histone Deacetylase InhibitorsIBA
01/2013
1AntibodiesIBA
01/2013
1AmelogeninIBA
01/2013
1Interleukin-22 (IL-22)IBA
11/2012
1neogeninIBA
11/2010

Therapy/Procedure

2Chemoradiotherapy
05/2016 - 05/2015
1Oral Administration
12/2019
1Nephrectomy
08/2019
1Injections
06/2018
1Drug Therapy (Chemotherapy)
05/2016
1Radiotherapy
05/2016
1Therapeutics
10/2015
1General Anesthesia
09/2013